Works matching IS 03407004 AND DT 2007 AND VI 56 AND IP 2
Results: 13
Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 2, p. 205, doi. 10.1007/s00262-006-0175-1
- By:
- Publication type:
- Article
Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 2, p. 249, doi. 10.1007/s00262-006-0177-z
- By:
- Publication type:
- Article
Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 2, p. 237, doi. 10.1007/s00262-006-0176-0
- By:
- Publication type:
- Article
In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 2, p. 155, doi. 10.1007/s00262-006-0181-3
- By:
- Publication type:
- Article
Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 2, p. 217, doi. 10.1007/s00262-006-0184-0
- By:
- Publication type:
- Article
Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 2, p. 193, doi. 10.1007/s00262-006-0185-z
- By:
- Publication type:
- Article
Immunotherapy success in prophylaxis cannot predict therapy: prime-boost vaccination against the 5T4 oncofoetal antigen.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 2, p. 165, doi. 10.1007/s00262-006-0179-x
- By:
- Publication type:
- Article
Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195–203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 2, p. 259, doi. 10.1007/s00262-006-0186-y
- By:
- Publication type:
- Article
Induction of an effective anti-tumor immune response and tumor regression by combined administration of IL-18 and Apoptin.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 2, p. 181, doi. 10.1007/s00262-006-0178-y
- By:
- Publication type:
- Article
Immune selective pressure and HLA class I antigen defects in malignant lesions.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 2, p. 227, doi. 10.1007/s00262-006-0183-1
- By:
- Publication type:
- Article
Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/ neu peptide (E75) and GM-CSF vaccine.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 2, p. 135, doi. 10.1007/s00262-006-0188-9
- By:
- Publication type:
- Article
The strange case of TGN1412.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Endowing self-binding feature restores the activities of a loss-of-function chimerized anti-GM2 antibody.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 2, p. 147, doi. 10.1007/s00262-006-0182-2
- By:
- Publication type:
- Article